Scarica l'app Stockscreener
12.26
0.43%
0.0529
Precedente Chiudi:
$12.20
Aprire:
$12.27
Volume 24 ore:
8,516
Relative Volume:
0.29
Capitalizzazione di mercato:
$57.53M
Reddito:
-
Utile/perdita netta:
$-24.77M
Rapporto P/E:
-16.79
EPS:
-0.73
Flusso di cassa netto:
$-17.36M
1 W Prestazione:
+16.61%
1M Prestazione:
-6.23%
6M Prestazione:
+68.12%
1 anno Prestazione:
+79.55%
Intervallo 1D:
$11.93
$12.34
Intervallo di 1 settimana:
$10.51
$12.37
Portata 52W:
$4.5601
$76.00
Mink Therapeutics Inc Stock (INKT) Company Profile
Nome
Mink Therapeutics Inc
Settore
Industria
Telefono
212-994-8250
Indirizzo
149 FIFTH AVENUE, NEW YORK
Confronta INKT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INKT
Mink Therapeutics Inc
|
12.26 | 57.97M | 0 | -24.77M | -17.36M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.70 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
729.43 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
462.33 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
904.45 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.81 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-07-14 | Downgrade | William Blair | Outperform → Mkt Perform |
Mink Therapeutics Inc Borsa (INKT) Ultime notizie
Why MiNK Therapeutics Inc. stock is favored by top institutionsWeekly Trading Summary & Community Verified Trade Signals - Newser
How Mink Therapeutics Inc. (INKT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Is MiNK Therapeutics Inc. (6Q40) stock inflation resilientQuarterly Profit Report & Daily Growth Stock Tips - Newser
What downside risks could hit MiNK Therapeutics Inc. (6Q40) stockJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - Newser
MiNK Therapeutics (INKT) Stock Analysis Report | Financials & Insights - Benzinga
Why MiNK Therapeutics Inc. (6Q40) stock appeals to dividend investorsQuarterly Trade Summary & Growth Focused Entry Point Reports - Newser
Will MiNK Therapeutics Inc. (6Q40) stock recover faster than industryStock Surge & Momentum Based Trading Signals - Newser
How MiNK Therapeutics Inc. (6Q40) stock compares with tech leaders2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - Newser
Published on: 2025-12-02 06:12:45 - Newser
Will MiNK Therapeutics Inc. (6Q40) stock outperform value peersMarket Activity Recap & Target Return Focused Stock Picks - Newser
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Why MiNK Therapeutics Inc. stock is seen as undervaluedEarnings Recap Report & Real-Time Volume Surge Alerts - moha.gov.vn
Buybacks Report: Why MiNK Therapeutics Inc. stock attracts global investorsM&A Rumor & Risk Managed Investment Signals - BỘ NỘI VỤ
(INKT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
MiNK Therapeutics Inc 6Q40 Stock Analysis and ForecastBull Market Opportunities & Learn From the Strategies of Institutions - earlytimes.in
MiNK Therapeutics Inc Stock Analysis and ForecastSupport Level Holds & Small Capital Trading Plans - earlytimes.in
MiNK Therapeutics announces publication of new preclinical data for MiNK-215 - MSN
How reliable is MiNK Therapeutics Inc. (6Q40) stock dividend growthEarnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
MiNK Therapeutics Advances iNKT Platform in Q3 2025 - MSN
MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors - The Manila Times
MiNK Therapeutics Announces New Data Showing MiNK-215 - GlobeNewswire
MiNK Therapeutics (NASDAQ: INKT) unveils MiNK-215 CAR-iNKT for solid tumors - Stock Titan
Why global investors buy MiNK Therapeutics Inc. (6Q40) stock - newser.com
How MiNK Therapeutics Inc. stock performs in rate cut cyclesBond Market & Community Shared Stock Ideas - newser.com
Mink Therapeutics Shares Slide After Announcing $50 Million Stock Offering - MSN
FY2025 EPS Estimate for MiNK Therapeutics Raised by Analyst - Defense World
Will MiNK Therapeutics Inc. stock see insider buyingJuly 2025 Sector Moves & Risk Managed Trade Strategies - newser.com
What’s next for MiNK Therapeutics Inc. stock priceBond Market & Verified Momentum Stock Watchlist - newser.com
Published on: 2025-11-19 15:48:22 - newser.com
Using fundamentals and technicals on MiNK Therapeutics Inc.2025 Biggest Moves & Free Safe Capital Growth Stock Tips - newser.com
Why analysts remain bullish on MiNK Therapeutics Inc. stockJuly 2025 Price Swings & Consistent Growth Equity Picks - newser.com
Is MiNK Therapeutics Inc. stock safe for conservative investors2025 Support & Resistance & Technical Confirmation Trade Alerts - newser.com
Can MiNK Therapeutics Inc. stock resist sector downturnsTrade Volume Summary & Entry Point Strategy Guides - newser.com
Mink Therapeutics Inc Azioni (INKT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
0.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):